Why To Keep Buying Revance Therapeutics Inc. (NASDAQ:RVNC) while S&P500 loss -0.03%
Revance Therapeutics Inc. (NASDAQ:RVNC) Relative Strength Index (RSI) is 66.50, with weekly volatility at 2.62% and ATR at 0.98. The RVNC stock’s 52-week price range